These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4902019)

  • 1. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta receptor blocking agents in hypercirculatory syndromes and in high performance athletes].
    Gattenlöhner W; Schneider KW; Rost R
    Med Welt; 1969 Oct; 42():2298-306. PubMed ID: 4901510
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of beta-receptor blocking agents propranolol and practolol on ST-T changes in neurocirculatory asthenia.
    Wolf E; Braun K; Stern S
    Br Heart J; 1974 Sep; 36(9):872-9. PubMed ID: 4425601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamics in patients suffering from hyperkinetic cardiac syndromes and in normal persons under psychological stress before and after treatment with propranolol (author's transl)].
    Magometschnigg D; Bonelli J; Kaik G
    Z Kardiol; 1979 Mar; 68(3):183-8. PubMed ID: 220809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a ganglionic blocking agent (chlorisondamine) on electrocardiogram, physical working capacity and hemodynamics in patients with vasoregulatory asthenia.
    Arvedson O; Furberg C; Linderholm H
    Acta Med Scand Suppl; 1967; 472():36-53. PubMed ID: 5231572
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term propranolol therapy in essential circulatory hyperkinesis.
    Török E; Bajkay G; Gulyás A; Istvánffy M; Matos L
    Int J Clin Pharmacol; 1972 Nov; 6(4):364-74. PubMed ID: 4629827
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic effects of propranolol in chronic lung diseases.
    Lockhart A; Schrijen F; Salmon D; Andrada L; Peslin R
    Clin Sci; 1967 Aug; 33(1):101-10. PubMed ID: 6059290
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-adrenergic blockade in the diagnosis of the ST-T complex in electrocardiography].
    Wiecko W; Szabelski R
    Wiad Lek; 1974 Jul; 27(14):1245-51. PubMed ID: 4417492
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
    Kelesidis G; Hagis P; Samaras C
    Indian Heart J; 1972 Jun; 24():Suppl 1:238-43. PubMed ID: 4147280
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation.
    Dufour R; Scazziga B; Schelling JL
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):145-7. PubMed ID: 4395480
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemodynamic effects of beta-adrenergic blockade in patients with neurocirculatory asthenia.
    Schweitzer P; Pivonka M; Gregorová J
    Cardiologia (Basel); 1968; 52(5):246-51. PubMed ID: 5713275
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperkinetic heart syndrome].
    Lohmöller G; Lydtin H
    Fortschr Med; 1971 Aug; 89(22):864-7. PubMed ID: 4403734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of the orthostasis syndrome in children and adolescents].
    Menner K
    Arch Kreislaufforsch; 1970; 61(1):27-63. PubMed ID: 4394141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the propranolol test in ambulatory cardiological diagnosis].
    Einaudi G; Pecchiura G
    Minerva Med; 1973 Jul; 64(5):2669-79. PubMed ID: 4790888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the sympathetic nervous system in functional cardiac disorders and the action of beta-adrenergic sympathetic blocking agents].
    Lichtig E; Georgescu M; Păun R
    Med Interna (Bucur); 1968 Feb; 20(2):163-74. PubMed ID: 5668963
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of age on the response to propranolol.
    Conway J
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):148-50. PubMed ID: 4924320
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Exertion insufficiency during beta blocker therapy in the hyperkinetic heart syndrome].
    Niehues B; Hermanns L; Kortenbruck R; Behrenbeck DW; Hilger HH
    Verh Dtsch Ges Inn Med; 1978; (84):736-9. PubMed ID: 742112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.